News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,618 Results
Type
Article (41736)
Company Profile (251)
Press Release (692619)
Multimedia
Podcasts (106)
Webinars (20)
Section
Business (204997)
Career Advice (2037)
Deals (35642)
Drug Delivery (138)
Drug Development (81755)
Employer Resources (173)
FDA (16566)
Job Trends (15007)
News (347216)
Policy (32824)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2614)
Accelerated approval (55)
ADA (44)
Adcomms (30)
Allergies (192)
Alliances (49591)
ALS (226)
Alzheimer's disease (1835)
Antibody-drug conjugate (ADC) (520)
Approvals (17041)
Artificial intelligence (726)
ASCO (328)
Autoimmune disease (344)
Automation (63)
Bankruptcy (364)
Best Places to Work (11641)
BIO (67)
BIOSECURE Act (20)
Biosimilars (232)
Biotechnology (161)
Bladder cancer (204)
Brain cancer (76)
Breast cancer (802)
Cancer (6308)
Cardiovascular disease (505)
Career advice (1733)
Career pathing (44)
CAR-T (355)
CDC (63)
Celiac Disease (3)
Cell therapy (962)
Cervical cancer (56)
Clinical research (71590)
Collaboration (2203)
Commercialization (1)
Company closure (5)
Compensation (1489)
Complete response letters (85)
COVID-19 (2842)
CRISPR (116)
C-suite (1232)
Cystic fibrosis (156)
Data (8642)
Decentralized trials (3)
Denatured (29)
Depression (173)
Dermatology (97)
Diabetes (663)
Diagnostics (7028)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (358)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (306)
Earnings (92231)
Editorial (70)
Employer branding (21)
Employer resources (153)
Events (120613)
Executive appointments (1125)
FDA (20590)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1853)
Gene editing (244)
Generative AI (62)
Gene therapy (750)
GLP-1 (1095)
Government (4798)
Grass and pollen (6)
Guidances (419)
Healthcare (19157)
Hematology (192)
HIV (90)
Huntington's disease (62)
IgA nephropathy (111)
Immunology and inflammation (300)
Immuno-oncology (104)
Indications (220)
Infectious disease (3213)
Inflammatory bowel disease (222)
Inflation Reduction Act (14)
Influenza (145)
Intellectual property (319)
Interviews (321)
IPO (16687)
IRA (51)
Job creations (3651)
Job search strategy (1433)
JPM (60)
Kidney cancer (20)
Labor market (111)
Layoffs (577)
Leadership (42)
Legal (7966)
Liver cancer (103)
Longevity (35)
Lung cancer (835)
Lymphoma (477)
Machine learning (65)
Management (60)
Manufacturing (1157)
Marketing (4)
MASH (209)
Medical affairs (1)
Medical device (13993)
Medtech (14165)
Mergers & acquisitions (20264)
Metabolic disorders (1652)
mRNA (251)
Multiple sclerosis (200)
NASH (17)
Neurodegenerative disease (458)
Neuropsychiatric disorders (110)
Neuroscience (3471)
Neurotech (1)
NextGen: Class of 2026 (6526)
Non-profit (4539)
Now hiring (83)
Obesity (763)
Opinion (296)
Ovarian cancer (240)
Pain (265)
Pancreatic cancer (352)
Parkinson's disease (393)
Partnered (35)
Patents (641)
Patient recruitment (769)
Peanut (67)
People (59925)
Pharmaceutical (56)
Pharmacy benefit managers (33)
Phase 1 (22324)
Phase 2 (31548)
Phase 3 (23477)
Pipeline (9835)
Policy (338)
Postmarket research (2570)
Preclinical (9479)
Press Release (64)
Prostate cancer (335)
Psychedelics (61)
Radiopharmaceuticals (344)
Rare diseases (1181)
Real estate (5974)
Recruiting (70)
Regulatory (25853)
Reports (56)
Research institute (2428)
Resumes & cover letters (354)
Rett syndrome (46)
RNA editing (25)
RSV (94)
Schizophrenia (182)
Series A (315)
Series B (233)
Service/supplier (11)
Sickle cell disease (120)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3654)
State (2)
Stomach cancer (18)
Supply chain (135)
Tariffs (87)
The Weekly (75)
Vaccines (1207)
Venture capital (122)
Weight loss (486)
Women's health (138)
Worklife (21)
Date
Today (113)
Last 7 days (485)
Last 30 days (2481)
Last 365 days (30377)
2026 (16168)
2025 (30190)
2024 (35227)
2023 (40087)
2022 (51203)
2021 (55760)
2020 (54120)
2019 (46540)
2018 (35019)
2017 (32117)
2016 (31485)
2015 (37552)
2014 (31318)
2013 (26349)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (745)
Alabama (93)
Alaska (7)
Arizona (365)
Arkansas (14)
Asia (39948)
Australia (6548)
California (13996)
Canada (3961)
China (1488)
Colorado (597)
Connecticut (612)
Delaware (434)
Europe (86475)
Florida (2113)
Georgia (447)
Hawaii (3)
Idaho (63)
Illinois (1151)
India (98)
Indiana (632)
Iowa (25)
Japan (597)
Kansas (133)
Kentucky (51)
Louisiana (58)
Maine (76)
Maryland (1660)
Massachusetts (10033)
Michigan (376)
Minnesota (756)
Mississippi (6)
Missouri (149)
Montana (33)
Nebraska (30)
Nevada (149)
New Hampshire (84)
New Jersey (3666)
New Mexico (30)
New York (3678)
North Carolina (1761)
North Dakota (9)
Northern California (7074)
Ohio (417)
Oklahoma (23)
Oregon (41)
Pennsylvania (2781)
Puerto Rico (31)
Rhode Island (52)
South America (1114)
South Carolina (87)
South Dakota (2)
Southern California (5546)
Tennessee (230)
Texas (2247)
United States (49363)
Utah (414)
Vermont (2)
Virginia (344)
Washington D.C. (81)
Washington State (1111)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
734,618 Results for "moderna inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Adcomms
Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership
The FDA in February briefly refused to review Moderna’s flu vaccine, citing trial inadequacies, but reversed course a few days later. A verdict is expected by Aug. 5.
June 19, 2026
·
2 min read
·
Tristan Manalac
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
Moderna appears to have aligned with the FDA ahead of an advisory committee meeting for its mRNA-based flu vaccine, which the regulator initially turned away in February; biotech IPOs are going gangbusters, including two new records raises in as many weeks; layoffs continue across biopharma; plus much more.
June 17, 2026
·
2 min read
·
Jef Akst
mRNA
ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival
When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in a mid-stage trial of advanced melanoma—a result analysts said could help “instill confidence” in the regimen.
June 2, 2026
·
2 min read
·
Tristan Manalac
Vaccines
FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna’s seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in February.
June 16, 2026
·
3 min read
·
Annalee Armstrong
Adcomms
Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm
After getting slapped with a surprise refuse-to-file letter signed by former CBER Director Vinay Prasad, Moderna’s flu vaccine application will now go before the FDA’s Vaccine advisory committee.
May 22, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Moderna’s stock rides hantavirus fears as spotlight returns to infectious disease platform
While the pathogen appears unlikely to trigger a pandemic, analysts see potential for Moderna to build goodwill amid a period of political pressure on vaccine manufacturers.
May 20, 2026
·
4 min read
·
Nick Paul Taylor
Manufacturing
Moderna mulls deals to rescue German BioNTech plants from closure: report
The takeovers depend on Moderna reaching an agreement with the German government, which risks losing investment from drugmakers over planned healthcare reforms.
June 18, 2026
·
2 min read
·
Nick Paul Taylor
Pipeline
Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms
Jefferies expects Moderna to have around seven commercial products in the coming years which, along with a projected 10% revenue growth, could help the company break even in 2028.
June 26, 2026
·
2 min read
·
Tristan Manalac
Podcast
Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds
Eli Lilly continues to spend its GLP-1 landfall with four new deals in the past week, including three in the vaccine space; the obesity leader also touted surgery-like results for its next-gen weight loss drug; Moderna’s stock climbs on the hantavirus “fear trade”; and in oncology, all eyes are on Revolution at ASCO this week.
May 27, 2026
·
2 min read
·
Jef Akst
Earnings
Moderna beats revenue expectations with $389M, but litigation dogs earnings
CEO Stéphane Bancel expressed confidence in Moderna’s first quarter, touting the revenue numbers as a sign of the company’s return to prosperity.
May 1, 2026
·
3 min read
·
Annalee Armstrong
1 of 73,462
Next